Scientific Session
Rheumatoid arthritis (RA)
Merete Hetland, MD, PhD
Rigshospitalet
Glostrup, Denmark
Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Terminated, December 31, 2021); Danbio: MLH has chaired the steering committee of the Danish Rheumatology Quality Registry (DANBIO, DRQ), which receives public funding from the hospital owne (Terminated, August 31, 2022); Eli Lilly: Grant/Research Support (Terminated, December 31, 2021); MEDAC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2022); Novartis: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Terminated, July 1, 2022), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 1, 2022); Sandoz: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)